Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000140

Chief Technology Officer sold 38,689 shares at an average $16.78 ($649,030)

  • Chief Technology Officer acquired 38,689 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kurtoglu Metin Chief Technology Officer 2024-11-19 Option exercise +200 $1.41 $282 51,233 D
Kurtoglu Metin Chief Technology Officer 2024-11-19 Sale −200 $19.50 $3,900 51,033 D
Kurtoglu Metin Chief Technology Officer 2024-11-20 Option exercise +5,700 $1.41 $8,037 56,733 D
Kurtoglu Metin Chief Technology Officer 2024-11-20 Sale −5,600 $17.28 $96,761 51,133 D
Kurtoglu Metin Chief Technology Officer 2024-11-20 Sale −100 $18.09 $1,809 51,033 D
Kurtoglu Metin Chief Technology Officer 2024-11-21 Option exercise +32,789 $1.41 $46,232 83,822 D
Kurtoglu Metin Chief Technology Officer 2024-11-21 Sale −32,789 $16.67 $546,560 51,033 D
Derivatives
Kurtoglu Metin Chief Technology Officer 2024-11-19 Option exercise · Stock Option (Right to Buy) −200 131,252 D
Kurtoglu Metin Chief Technology Officer 2024-11-20 Option exercise · Stock Option (Right to Buy) −5,700 125,552 D
Kurtoglu Metin Chief Technology Officer 2024-11-21 Option exercise · Stock Option (Right to Buy) −32,789 92,763 D
Open-market sales · 38,689 sh · avg $16.78 · $649,030
Loading xslF345X05/wk-form4_1732233135.xml…